Peter G. Linde

Sotatercept for the Treatment of Pulmonary Arterial Hypertension

Marc Humbert, Vallerie V. McLaughlin, J. Simon R. Gibbs et al. · New England Journal of Medicine · 2021 · 585 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Pierre Fenaux, Uwe Platzbecker, Ghulam J. Mufti et al. · New England Journal of Medicine · 2020 · 537 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

Maria Domenica Cappellini, Vip Viprakasit, Alì Taher et al. · New England Journal of Medicine · 2020 · 306 citations

Medicine, Hematology, Molecular Medicine +13

Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl

Melanie Chin, Danielle Wrolstad, George L. Bakris et al. · Journal of Cardiac Failure · 2014 · 159 citations · Full text

Medicine, Cardiology, Pharmacology +15

Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl

Melanie Chin, Scott A. Reisman, George L. Bakris et al. · American Journal of Nephrology · 2014 · 149 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14